scholarly journals Investigating Stakeholder Attitudes and Opinions on School-Based Human Papillomavirus Vaccination Programs

2015 ◽  
Vol 85 (5) ◽  
pp. 289-298 ◽  
Author(s):  
Jessica A. Nodulman ◽  
Randall Starling ◽  
Alberta S. Kong ◽  
David B. Buller ◽  
Cosette M. Wheeler ◽  
...  
2016 ◽  
Vol 22 (10) ◽  
pp. 1732-1740 ◽  
Author(s):  
David Mesher ◽  
Kate Soldan ◽  
Matti Lehtinen ◽  
Simon Beddows ◽  
Marc Brisson ◽  
...  

2021 ◽  
Vol 2 (2) ◽  
pp. 85-93
Author(s):  
Suzanne Audrey ◽  
Karen Evans ◽  
Michelle Farr ◽  
Joanne Ferrie ◽  
Julie Yates ◽  
...  

Background The requirement for written parental consent for school-based human papillomavirus vaccination programme in England can act as a barrier to uptake for some young women, with the potential to exacerbate health inequities. Aims To consider the practicalities and implications of implementing new consent procedures, including parental telephone consent and adolescent self-consent, in two local authority areas in the southwest of England. Methods Digitally recorded, semi-structured interviews were conducted with 53 participants, including immunisation nurses, school staff, young people, and parents. All interviews were fully transcribed and thematic analysis was undertaken. Results Parental telephone consent was welcomed by the immunisation nurses, parents, and young women in the study. Adolescent self-consent was rare. Greater understanding of the barriers to uptake outside of mainstream school-based sessions is needed to further address inequalities in uptake. Conclusions The new procedures generally worked well but some important barriers to vaccination uptake remain.


2004 ◽  
Vol 10 (11) ◽  
pp. 1915-1923 ◽  
Author(s):  
Al V. Taira ◽  
Christopher P. Neukermans ◽  
Gillian D. Sanders

2019 ◽  
Vol 8 ◽  
pp. 100189 ◽  
Author(s):  
Sapna Kaul ◽  
Thuy Quynh N. Do ◽  
Enshuo Hsu ◽  
Kathleen M. Schmeler ◽  
Jane R. Montealegre ◽  
...  

2009 ◽  
Vol 19 (9) ◽  
pp. 1610-1613 ◽  
Author(s):  
Katharine Astbury ◽  
Michael J. Turner

Cervical cancer remains a major cause of morbidity and mortality for women worldwide. Although the introduction of comprehensive screening programs has reduced the disease incidence in developed countries, it remains a major problem in the developing world. The recent licensing of 2 vaccines against human papillomavirus (HPV) type 16 and HPV-18, the viruses responsible for 70% of cervical cancer cases, offers the hope of disease prevention. In this article, we review the role of HPV in the etiology of cervical cancer and the evidence to support the introduction of vaccination programs in young women and discus the potential obstacles to widespread vaccination. In addition, we discuss the issues that remain to be elucidated, including the potential need for booster doses of the vaccine and the role of concomitant vaccination in men.


Sign in / Sign up

Export Citation Format

Share Document